Webinar replay

After the Biotech Bubble Bursts

After a decade where deal volumes expanded, biotech valuations exploded, and venture capital flooded the biopharma market like never before, the public biotech bubble has burst. So, now what? Pharma will still seek external innovation, biotechs will still need investment, but what will the post-bubble landscape look like and how can innovative science successfully emerge?

Analyst and journalist Melanie Senior joins long-time biopharma investor Stephan Christgau, Founding Partner at EIR Ventures, Dr. Steven Cohen, Executive Director at Daiichi Sankyo, and Dylan van Haaften, Managing Director at Bryan, Garnier & Co. to discuss what a bursting biotech bubble means for dealmaking, innovation, and the industry. They discussed what to expect in the investment market in the year ahead, where investments will continue to grow and where they may dry up, and how biotechs and pharma companies can position themselves for success in a post-bubble market.

Watch this replay to get expert insights from our panelists:
melanie senior
Melanie Senior
Analyst and Journalist
Stephan Christgau
Stephan Christgau
Founding Partner
EIR Ventures
steven cohen
Steven Cohen
Executive Director
Daiichi Sankyo
dylan v haaften
Dylan van Haaften
Managing Director
Bryan, Garnier & Co.

Please complete the form below

All fields marked with a * are required.

By submitting this form, you agree to the storing and processing of your
personal data by Inova as detailed in the Privacy Statement.

About Inova

Inova accelerates the find, deal, and collaborate phases of biopharma partnering. Its market-leading platform is used by 60% of the world’s top 50 pharma companies to source and manage their opportunities efficiently, and its technology powers more than 50,000 partnering meetings each year at the world's most important biopharma partnering conferences, including the BIO International Convention.
With subsidiaries Labiotech and IN-PART, Inova reaches more than 100,000 readers in life sciences a month and connects a network of 6,500 industry players and academic organizations.